Clifutinib Besylate Clinical Trials

1 actively recruiting trial

Also known as: HEC73543

Pipeline

Phase 1/2: 1

Top Sponsors

Sunshine Lake Pharma Co., Ltd.1

Indications

Acute Myeloid Leukemia, Adult1
Cancer1

Other1 trial

A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.